Navegar

Colección

Datos Estadísticas

Artículo

Kim, Y.-C.; Gallo-Rodriguez, C.; Jang, S.-Y.; Nandanan, E.; Adams, M.; Harden, T.K.; Boyer, J.L.; Jacobson, K.A. "Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists" (2000) Journal of Medicinal Chemistry. 43(4):746-755
Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

P2Y 1 receptors are activated by ADP and occur on endothelial cells, smooth muscle, epithelial cells, lungs, pancreas, platelets, and in the central nervous system. With the aid of molecular modeling, we have designed nucleotide analogues that act as selective antagonists at this subtype. The present study has tested the hypothesis that acyclic modifications of the ribose ring, proven highly successful for nucleoside antiviral agents such as gancyclovir, are generalizable to P2Y receptor ligands. Specifically, the binding site of the P2Y 1 receptor was found to be sufficiently accommodating to allow the substitution of the ribose group with acyclic aliphatic and aromatic chains attached to the 9-position of adenine. Three groups of adenine derivatives having diverse side-chain structures, each containing two symmetrical phosphate or phosphonate groups, were prepared. Biological activity was demonstrated by the ability of the acyclic derivatives to act as agonists or antagonists in the stimulation of phospholipase C in turkey erythrocyte membranes. An acyclic N 6 -methyladenine derivative, 2-[2-(6- methylaminopurin-9-yl)-ethyl]-propane-1,3-bisoxy(diammoniumphosphate) (10), containing an isopentyl bisphosphate moiety, was a full antagonist at the P2Y 1 receptor with an IC 50 value of 1.60 μM. The corresponding 2-Cl derivative (11) was even more potent with an IC 50 value of 0.84 μM. Homologation of the ethylene group at the 9-position to 3-5 methylene units or inclusion of cis- or trans-olefinic groups greatly reduced antagonist potency at the P2Y 1 receptor. Analogues containing a diethanolamine amide group and an aryl di(methylphosphonate) were both less potent than 10 as antagonists, with IC 50 values of 14 and 16 μM, respectively, and no agonist activity was observed for these analogues. Thus, the ribose moiety is clearly not essential for recognition by the turkey P2Y 1 receptor, although a cyclic structure appears to be important for receptor activation, and the acyclic approach to the design of P2 receptor antagonists is valid.

Registro:

Documento: Artículo
Título:Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists
Autor:Kim, Y.-C.; Gallo-Rodriguez, C.; Jang, S.-Y.; Nandanan, E.; Adams, M.; Harden, T.K.; Boyer, J.L.; Jacobson, K.A.
Filiación:Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institutes of Health, Bethesda, MD 20892-0810, United States
Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill, NC 27599-7365, United States
CIHIDECAR, Departamento de Quimica Organica, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina
Molecular Recognition Section, Bldg. 8A, NIH, Bethesda, MD 20892-0810, United States
Palabras clave:2 [2 (2 chloro 6 methylaminopurin 9 yl)ethyl]propane 1,3 bisoxy(diammoniumphosphate); 2 [2 (6 methylaminopurin 9 yl)ethyl]propane 1,3 bisoxy(diammoniumphosphate); deoxyadenosine derivative; ethylene derivative; ganciclovir; phospholipase C; purine P2Y receptor; purinergic receptor blocking agent; receptor subtype; unclassified drug; animal cell; article; cis isomer; controlled study; drug potency; drug receptor binding; drug structure; drug synthesis; enzyme activation; nonhuman; reaction analysis; receptor blocking; structure activity relation; trans isomer; Adenine; Deoxyadenosines; Diphosphonates; Erythrocytes; Inositol Phosphates; Phosphoric Acid Esters; Receptors, Purinergic P2; Structure-Activity Relationship; Turkey
Año:2000
Volumen:43
Número:4
Página de inicio:746
Página de fin:755
DOI: http://dx.doi.org/10.1021/jm9905211
Título revista:Journal of Medicinal Chemistry
Título revista abreviado:J. Med. Chem.
ISSN:00222623
CODEN:JMCMA
CAS:2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate); Adenine, 73-24-5; Deoxyadenosines; Diphosphonates; Inositol Phosphates; Phosphoric Acid Esters; purinoceptor P2Y1; Receptors, Purinergic P2
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00222623_v43_n4_p746_Kim

Referencias:

  • Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Dubyak, G.R., Harden, T.K., Jacobson, K.A., Schwabe, U., Williams, M., Toward a revised nomenclature for P1 and P2 receptors (1997) Trends Pharm. Sci., 18, pp. 79-82
  • North, R.A., Barnard, E.A., Nucleotide receptors (1997) Curr. Opin. Neurobiol., 7, pp. 346-357
  • Bhagwhat, S.S., Williams, M., P2 purine and pyrimidine receptors: Emerging superfamilies of G protein and ligand-gated ion channel receptors (1997) Eur. J. Med. Chem., 32, pp. 183-193
  • Fischer, B., Therapeutic applications of ATP-(P2) receptors agonists and antagonists (1999) Exp. Opin. Ther. Patents, 9, pp. 385-399
  • Jacobson, K.A., Knutsen, L.J.S., P1 and P2 purine and pyrimidine receptors Handbook of Experimental Pharmacology, , Abbracchio, M. P., Williams, M., Eds.; in press
  • Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., Smart, T.G., King, B.F., Burnstock, G., Barnard, E.A., Cloning and functional expression of a brain G-protein-coupled ATP receptor (1993) Febs Lett, 324, pp. 219-225
  • Henderson, D.J., Elliot, D.G., Smith, G.M., Webb, T.E., Dainty, I.A., Cloning and characterization of a bovine P2Y receptor (1995) Biochem. Biophys. Res. Commun., 212, pp. 648-656
  • King, B.F., Townsend-Nicholson, A., Burnstock, G., Metabotropic receptors for ATP and UTP: Exploring the correspondence between native and recombinant nucleotide receptors (1998) Trends Pharmacol. Sci., 19, pp. 506-514
  • Boarder, M.R., Hourani, S.M.O., The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors (1998) Trends Pharmacol. Sci., 19, pp. 99-107
  • Communi, D., Paindavoine, P., Place, G.A., Parmentier, M., Boeynaems, J.M., Expression of P2Y receptors in cell lines derived from the human lung (1999) Br. J. Pharmacol., 127, pp. 562-568
  • Jin, J., Daniel, J.L., Kunapuli, S.P., Molecular basis for ADP-induced platelet activation. II. The P2Y 1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets (1998) J. Biol. Chem., 273, pp. 2030-2034
  • Petit, P., Hillaire-Buys, D., Manteghetti, M., Debrus, S., Chapal, J., Loubatieres-Mariani, M.M., Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell (1998) Br. J. Pharmacol., 125, pp. 1368-1374
  • Bolego, C., Centemeri, C., Abbracchio, M.P., Ceruti, S., Cattabeni, F., Jacobson, K.A., Puglisi, L., Nicosia, S., Characterization of P2Y receptors involved in UTP- and purine-evoked Ca 2+ elevation in mammalian brain astrocytes Glia, , submitted
  • Boyer, J.L., Romero-Avila, T., Schachter, J.B., Harden, T.K., Identification of competitive antagonists of the P2Y 1 receptor (1996) Mol. Pharmacol., 50, pp. 1323-1329
  • Camaioni, E., Boyer, J.L., Mohanram, A., Harden, T.K., Jacobson, K.A., Deoxyadenosine-bisphosphate derivatives as potent antagonists at P2Y 1 receptors (1998) J. Med. Chem., 41, pp. 183-190
  • Boyer, J.L., Mohanram, A., Camaioni, E., Jacobson, K.A., Harden, T.K., Competitive and selective antagonism of P2Y 1 receptors by N 6 -methyl 2′-deoxyadenosine 3′,5′-bisphosphate (1998) Br. J. Pharmacol., 124, pp. 1-3
  • Nandanan, E., Camaioni, E., Jang, S.Y., Kim, Y.-C., Cristalli, G., Herdewijn, P., Secrist, J.A., Jacobson, K.A., Structure activity relationships of bisphosphate nucleotide derivatives as P2Y 1 receptor antagonists and partial agonists (1999) J. Med. Chem., 42, pp. 1625-1638
  • Nandanan, E., Jang, S.Y., Moro, S., Kim, H., Siddiqi, M.A., Russ, P., Marquez, V., Jacobson, K.A., Synthesis, biological activity, and molecular modeling of ribose-modified adenosine bisphosphate analogues as P2Y 1 receptor ligands (1999) J. Med. Chem., , in press
  • Moro, S., Guo, D., Camaioni, E., Boyer, J.L., Harden, K.T., Jacobson, K.A., Human P2Y 1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites (1998) J. Med. Chem., 41, pp. 1456-1466
  • Freeman, S., Gardiner, J.M., Acyclic nucleosides as antiviral compounds (1996) Mol. Biotechnol., 5, pp. 125-137
  • Martin, J.C., Dvorak, C.A., Smee, D.F., Matthews, T.R., Verheyden, J.P.H., 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: A new potent and selective antiherpes agent (1983) J. Med. Chem., 26, pp. 759-761
  • Choudary, B.M., Geen, G.R., Kincey, P.M., Parratt, M.J., A direct approach to the synthesis of famciclovir and penciclovir (1996) Nucleosides Nucleotides, 15, pp. 981-994
  • Boyer, J.L., Downes, C.P., Harden, T.K., Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides (1989) J. Biol. Chem., 264, pp. 884-890
  • Filtz, T.M., Li, Q., Boyer, J.L., Nicholas, R.A., Harden, T.K., Expression of a cloned P2Y purinergic receptor that couples to phospholipase C (1994) Mol. Pharmacol., 46, pp. 8-14
  • Harden, T.K., Hawkins, P.T., Stephens, L., Boyer, J.L., Downes, P., Phosphoinositide hydrolysis by guanosine 5′-gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes (1988) Biochem. J., 252, pp. 583-593
  • Fischer, B., Boyer, J.L., Hoyle, C.H.V., Ziganshin, A.U., Brizzolara, A.L., Knight, G.E., Zimmet, J., Jacobson, K.A., Identification of potent, selective P2Y-purinoceptor agonists - Structure-activity-relationships for 2-thioether derivatives of adenosine 5′-triphosphate (1993) J. Med. Chem., 36, pp. 3937-3946
  • Fischer, B., Yefidoff, R., Major, D.T., Rutman-Halili, I., Shneyvays, V., Zinman, T., Jacobson, K.A., Shainberg, A., Characterization of "mini-nucleotides" as P2X receptor agonists in rat cardiomyocyte cultures. An integrated synthetic, biochemical, and theoretical study (1999) J. Med. Chem., 42, pp. 2685-2696
  • Hechler, B., Leon, C., Vial, C., Vigne, P., Frelin, C., Cazenave, J.P., Gachet, C., The P2Y 1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation (1998) Blood, 92, pp. 152-159
  • Fagura, M.S., Dainty, I.A., McKay, G.D., Kirk, I.P., Humphries, R.G., Robertson, M.J., Dougall, I.G., Leff, P., P2Y 1 -receptors in human platelets which are pharmacologically distinct from P2Y ADP -receptors (1998) Br. J. Pharmacol., 124, pp. 157-164
  • Brown, S.G., King, B.F., Kim, Y.-C., Burnstock, G., Jacobson, K.A., Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors (2000) Drug Dev. Res., , in press

Citas:

---------- APA ----------
Kim, Y.-C., Gallo-Rodriguez, C., Jang, S.-Y., Nandanan, E., Adams, M., Harden, T.K., Boyer, J.L.,..., Jacobson, K.A. (2000) . Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists. Journal of Medicinal Chemistry, 43(4), 746-755.
http://dx.doi.org/10.1021/jm9905211
---------- CHICAGO ----------
Kim, Y.-C., Gallo-Rodriguez, C., Jang, S.-Y., Nandanan, E., Adams, M., Harden, T.K., et al. "Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists" . Journal of Medicinal Chemistry 43, no. 4 (2000) : 746-755.
http://dx.doi.org/10.1021/jm9905211
---------- MLA ----------
Kim, Y.-C., Gallo-Rodriguez, C., Jang, S.-Y., Nandanan, E., Adams, M., Harden, T.K., et al. "Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists" . Journal of Medicinal Chemistry, vol. 43, no. 4, 2000, pp. 746-755.
http://dx.doi.org/10.1021/jm9905211
---------- VANCOUVER ----------
Kim, Y.-C., Gallo-Rodriguez, C., Jang, S.-Y., Nandanan, E., Adams, M., Harden, T.K., et al. Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y 1 receptor antagonists. J. Med. Chem. 2000;43(4):746-755.
http://dx.doi.org/10.1021/jm9905211